CapsoVision, Inc (CV)
CapsoVision, Inc brought in $13.9M of revenue over the twelve months to June 30, 2026. It posted a net loss of $29.8M. In fiscal 2025 capital spending exceeded operating cash flow by $23M. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
What CapsoVision, Inc does
CapsoVision, Inc is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on NASDAQ under the ticker CV.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $13.6M | -$25.3M | -$1.03 | -$23M |
| 2025 | $11.8M | -$19.9M | -$9.85 | -$20.2M |
Latest SEC filings
What CapsoVision, Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 18, 2026
- September 18, 2026
- August 21, 2026
- August 18, 2026Other event 8-K
- August 13, 2026
- August 13, 2026Quarterly report 10-Q · period to June 30, 2026
- August 13, 2026
- July 2, 2026
- June 12, 2026
- May 14, 2026Quarterly report 10-Q · period to March 31, 2026
Questions about CV
What does CapsoVision, Inc do?
CapsoVision, Inc is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on NASDAQ under the ticker CV.
Is CapsoVision, Inc profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $29.8M on revenue of $13.9M.
How much revenue does CapsoVision, Inc make?
Over the twelve months to June 30, 2026 CapsoVision, Inc reported revenue of $13.9M.
When did CapsoVision, Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 23, 2026.
Similar companies
Follow CV
Get an email when CapsoVision, Inc files with the SEC: results, executive changes, material agreements and annual reports.
Follow CV: get an email when it filesWhere the numbers come from
Financial figures are the values CapsoVision, Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.